contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


conference-call-regarding-interim-report-q3-2

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Surgical Science Sweden operates in the medical technology sector. The company develops VR simulators in surgery. The simulators consist of both hardware and software that are used in training and personal development for surgeons. The hardware simulates various surgical procedures, primarily used in keyhole surgery and endoscopy. The vision is to strengthen expertise in surgery and create conditions for better treatments. The headquarters are located in Gothenburg.

Surgical Science Sweden

Invitation to attend Surgical Science's conference call regarding presentation of the interim report January-September 2025. The presentation will be held in English.Time: Thursday, November...

<div class="mfn-preamble">Invitation to attend Surgical Science's conference call regarding presentation of the interim report January-September 2025. The presentation will be held in English.</div><div class="mfn-body">Time: Thursday, November 13 at 11:00 a.m. CETIf you wish to participate via webcast, please use the link below. It will be possible to ask written questions via the webcast. <a rel="noopener" href="https://surgical-science-sweden.events.inderes.com/q3-report-2025/register">https://surgical-science-sweden.events.inderes.com/q3-report-2025/register</a>If you wish to participate via teleconference, please register via the link below. After registration, you will receive phone numbers and a conference ID to access the conference. It will be possible to ask oral questions via the telephone conference. <a rel="noopener" href="https://events.inderes.com/surgical-science-sweden/q3-report-2025/dial-in">https://events.inderes.com/surgical-science-sweden/q3-report-2025/dial-in</a>Participants from Surgical Science are: Tom Englund, CEO Anna Ahlberg, CFO &nbsp; A press release with Surgical Science's interim report for January-September 2025 will be published on November 13, 2025 at 07:30 a.m. CET.Prior to the start of the conference call, presentation material will be available on the company's website, under Investors, Presentations. &nbsp; Gothenburg, Sweden, November 3, 2025 Surgical Science Sweden AB (publ)The press release, in its entirety, is available through the attachment or via: <a rel="noopener" href="https://surgicalscience.com/investor-relations/#press-releases">https://surgicalscience.com/investor-relations/#press-releases</a>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.</div><div class="mfn-footer mfn-contacts mfn-641786c7ad88">For further information, please contact:<hr>Tom Englund, CEO Telephone: +46-70-916 16 81 E-mail:&nbsp;<a rel="noopener" href="mailto:tom.englund@surgicalscience.com">tom.englund@surgicalscience.com</a>Anna Ahlberg, CFO Telephone: +46-70-855 38 35 E-mail:&nbsp;<a rel="noopener" href="mailto:anna.ahlberg@surgicalscience.com">anna.ahlberg@surgicalscience.com</a></div><div class="mfn-footer mfn-about mfn-cd84c254f9cb">About Surgical Science Sweden AB (publ)<hr>Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge.&nbsp;Surgical Science has approximately 330 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Seattle and Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB.&nbsp;</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/94dc6d6b-2028-42f1-85f5-b3a98e2e26f5/conference-call-regarding-interim-report-q3.pdf" class="mfn-generated mfn-primary">Conference call regarding interim report Q3</a></div>